Lantheus Holdings, Inc. Accounts Receivable, Allowance for Credit Loss, Current
Lantheus Holdings, Inc. (LNTH) had Accounts Receivable, Allowance for Credit Loss, Current of $907.00 thousand as of 2016-09-30, per its 10-Q filed 2016-11-01.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent · last filed 2016-11-01
- 2016-09-30: Accounts Receivable, Allowance for Credit Loss, Current $907.00K.
- 2016-06-30: Accounts Receivable, Allowance for Credit Loss, Current $989.00K.
- 2016-03-31: Accounts Receivable, Allowance for Credit Loss, Current $1.05M.
- 2015-12-31: Accounts Receivable, Allowance for Credit Loss, Current $881.00K; Accounts Receivable, Allowance for Credit Loss, Current as first filed $900.00K.
| Period end | Accounts Receivable, Allowance for Credit Loss, Current | Accounts Receivable, Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2016-09-30 | $907.00K 10-Q · filed 2016-11-01 | |
| 2016-06-30 | $989.00K 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $1.05M 10-Q · filed 2016-05-03 | |
| 2015-12-31 | $881.00K 10-Q · filed 2016-11-01 | $900.00K 10-K · filed 2016-03-02 |
| 2015-09-30 | $334.00K 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $502.00K 10-Q · filed 2015-08-05 | |
| 2014-12-31 | $600.00K 10-K · filed 2016-03-02 | $585.00K 10-Q · filed 2015-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |